The interplay between suicidal experiences, psychotic experiences and interpersonal relationships: a qualitative study
- PMID: 38001403
- PMCID: PMC10668454
- DOI: 10.1186/s12888-023-05164-2
The interplay between suicidal experiences, psychotic experiences and interpersonal relationships: a qualitative study
Abstract
Background: Suicidal thoughts, acts, plans and deaths are considerably more prevalent in people with non-affective psychosis, including schizophrenia, compared to the general population. Social isolation and interpersonal difficulties have been implicated in pathways which underpin suicidal experiences in people with severe mental health problems. However, the interactions between psychotic experiences, such as hallucinations and paranoia, suicidal experiences, and the presence, and indeed, absence of interpersonal relationships is poorly understood and insufficiently explored. The current study sought to contribute to this understanding.
Methods: An inductive thematic analysis was conducted on transcripts of 22, individual, semi-structured interviews with adult participants who had both non-affective psychosis and recent suicidal experiences. A purposive sampling strategy was used. Trustworthiness of the analysis was assured with researcher triangulation.
Results: Participants relayed both positive and negative experiences of interpersonal relationships. A novel conceptual model is presented reflecting a highly complex interplay between a range of different suicidal experiences, psychosis, and aspects of interpersonal relationships. Three themes fed into this interplay, depicting dynamics between perceptions of i. not mattering and mattering, ii. becoming disconnected from other people, and iii. constraints versus freedom associated with sharing suicidal and psychotic experiences with others.
Conclusion: This study revealed a detailed insight into ways in which interpersonal relationships are perceived to interact with psychotic and suicidal experiences in ways that can be both beneficial and challenging. This is important from scientific and clinical perspectives for understanding the complex pathways involved in suicidal experiences.
Trial registration: ClinicalTrials.gov (NCT03114917), 14th April 2017. ISRCTN (reference ISRCTN17776666 .); 5th June 2017). Registration was recorded prior to participant recruitment commencing.
Keywords: Interpersonal relationships; Interviews; Non-affective psychosis; Qualitative methods; Schizophrenia; Suicidal behaviours; Suicidal experiences; Suicidal thoughts; Suicidality.
© 2023. The Author(s).
Conflict of interest statement
RE is supported by an NIHR Research Professorship (NIHR300051) and the NIHR Maudsley Biomedical Research Centre, part of the NIHR and hosted by South London and Maudsley NHS Foundation Trust in partnership with King's College London. No other co-authors have competing interests or conflicts of interest to declare.
Figures
Similar articles
-
How individuals with psychosis develop and maintain resilience to suicidal experiences through psychological therapy: a qualitative study.BMC Psychiatry. 2024 Dec 3;24(1):874. doi: 10.1186/s12888-024-06071-w. BMC Psychiatry. 2024. PMID: 39623399 Free PMC article.
-
A psychological intervention for suicide applied to non-affective psychosis: the CARMS (Cognitive AppRoaches to coMbatting Suicidality) randomised controlled trial protocol.BMC Psychiatry. 2020 Jun 16;20(1):306. doi: 10.1186/s12888-020-02697-8. BMC Psychiatry. 2020. PMID: 32546129 Free PMC article.
-
Influence of perceived harm due to substance use on the relationships between positive psychotic experiences and suicidal experiences in people with non-affective psychosis.Psychol Med. 2024 Oct 4;54(12):1-11. doi: 10.1017/S0033291724001764. Online ahead of print. Psychol Med. 2024. PMID: 39364657 Free PMC article.
-
Psychological Resilience to Suicidal Experiences in People with Non-Affective Psychosis: A Position Paper.Int J Environ Res Public Health. 2022 Mar 23;19(7):3813. doi: 10.3390/ijerph19073813. Int J Environ Res Public Health. 2022. PMID: 35409502 Free PMC article. Review.
-
Association of Psychotic Experiences With Subsequent Risk of Suicidal Ideation, Suicide Attempts, and Suicide Deaths: A Systematic Review and Meta-analysis of Longitudinal Population Studies.JAMA Psychiatry. 2019 Feb 1;76(2):180-189. doi: 10.1001/jamapsychiatry.2018.3514. JAMA Psychiatry. 2019. PMID: 30484818 Free PMC article.
Cited by
-
Risk factors for suicidal ideation among survivors of suicide loss using a psychological support hotline.Front Psychiatry. 2025 Feb 17;16:1513838. doi: 10.3389/fpsyt.2025.1513838. eCollection 2025. Front Psychiatry. 2025. PMID: 40034182 Free PMC article.
-
How individuals with psychosis develop and maintain resilience to suicidal experiences through psychological therapy: a qualitative study.BMC Psychiatry. 2024 Dec 3;24(1):874. doi: 10.1186/s12888-024-06071-w. BMC Psychiatry. 2024. PMID: 39623399 Free PMC article.
References
-
- Harris K, Gooding P, Peters S, Haddock G. Investigating the perceived impact of psychosis on suicidal thoughts and behaviors. Schizophrenia Bulletin Open. 2020;1(1):38. doi: 10.1093/schizbullopen/sgaa038. - DOI
-
- Tarrier N, Gooding P, Pratt D, Kelly J, Awenat Y, Maxwell J. Cognitive behavioural prevention of suicide in psychosis: A treatment manual. London, UK: Routledge; 2013.
-
- Chapman CL, Mullin K, Ryan CJ, Kuffel A, Nielssen O, Large MM. Meta-analysis of the association between suicidal ideation and later suicide among patients with either a schizophrenia spectrum psychosis or a mood disorder. Acta Psychiatr Scand. 2015;131(3):162–173. doi: 10.1111/acps.12359. - DOI - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- 13/161/25/Efficacy and Mechanism Evaluation Programme
- 13/161/25/Efficacy and Mechanism Evaluation Programme
- 13/161/25/Efficacy and Mechanism Evaluation Programme
- 13/161/25/Efficacy and Mechanism Evaluation Programme
- 13/161/25/Efficacy and Mechanism Evaluation Programme
- 13/161/25/Efficacy and Mechanism Evaluation Programme
- 13/161/25/Efficacy and Mechanism Evaluation Programme
- 13/161/25/Efficacy and Mechanism Evaluation Programme
- 13/161/25/Efficacy and Mechanism Evaluation Programme
- 13/161/25/Efficacy and Mechanism Evaluation Programme
- 13/161/25/Efficacy and Mechanism Evaluation Programme
- 13/161/25/Efficacy and Mechanism Evaluation Programme
- 13/161/25/Efficacy and Mechanism Evaluation Programme
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous